These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 20051944
1. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies. Tung HD, Wang JH, Tseng PL, Hung CH, Kee KM, Chen CH, Chang KC, Lee CM, Changchien CS, Chen YD, Lu SN. Am J Gastroenterol; 2010 Mar; 105(3):624-31. PubMed ID: 20051944 [Abstract] [Full Text] [Related]
2. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, Lu SN. J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888 [Abstract] [Full Text] [Related]
3. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ. Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617 [Abstract] [Full Text] [Related]
4. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan. Chen CT, Chen JY, Wang JH, Chang KC, Tseng PL, Kee KM, Chen PF, Tsai LS, Chen SC, Lin SC, Lu SN. Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236 [Abstract] [Full Text] [Related]
5. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS. Cancer; 2006 Nov 01; 107(9):2212-22. PubMed ID: 17019738 [Abstract] [Full Text] [Related]
6. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Hepatology; 2002 Nov 01; 36(5):1206-13. PubMed ID: 12395331 [Abstract] [Full Text] [Related]
7. Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: a surveillance study. Chang KC, Lu SN, Chen PF, Hung CH, Kee KM, Yen YH, Wang JH. Kaohsiung J Med Sci; 2011 Mar 01; 27(3):85-90. PubMed ID: 21421195 [Abstract] [Full Text] [Related]
8. Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors? Davila JA. Am J Gastroenterol; 2010 Mar 01; 105(3):632-4. PubMed ID: 20203644 [Abstract] [Full Text] [Related]
9. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. El-Serag HB, Richardson PA, Everhart JE. Am J Gastroenterol; 2001 Aug 01; 96(8):2462-7. PubMed ID: 11513191 [Abstract] [Full Text] [Related]
10. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD. Liver Int; 2005 Apr 01; 25(2):236-41. PubMed ID: 15780044 [Abstract] [Full Text] [Related]
11. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P. Cancer Epidemiol Biomarkers Prev; 2009 Jul 01; 18(7):2054-60. PubMed ID: 19549812 [Abstract] [Full Text] [Related]
12. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Wang CS, Yao WJ, Wang ST, Chang TT, Chou P. Clin Infect Dis; 2004 Sep 15; 39(6):790-6. PubMed ID: 15472809 [Abstract] [Full Text] [Related]
13. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690 [Abstract] [Full Text] [Related]
14. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Lai MS, Hsieh MS, Chiu YH, Chen TH. Hepatology; 2006 Jun 15; 43(6):1295-302. PubMed ID: 16729295 [Abstract] [Full Text] [Related]
15. Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C-endemic area: cross-sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination. Kao JT, Wang JH, Hung CH, Hu TH, Lee CM, Hung SF, Lu SN. Liver Int; 2008 Nov 15; 28(9):1298-304. PubMed ID: 18662273 [Abstract] [Full Text] [Related]
17. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. J Gastroenterol Hepatol; 2007 Jul 15; 22(7):1104-11. PubMed ID: 17559381 [Abstract] [Full Text] [Related]
18. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Chen DS. Princess Takamatsu Symp; 1995 Jul 15; 25():27-32. PubMed ID: 8875606 [Abstract] [Full Text] [Related]
19. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan. Kee KM, Lu SN. Oncology; 2011 Jul 15; 81 Suppl 1():36-40. PubMed ID: 22212934 [Abstract] [Full Text] [Related]
20. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G. Hepatology; 1997 Sep 15; 26(3):579-84. PubMed ID: 9303486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]